ELB-011

N/A

Report date: 2024/11/05 16:40:42

Base Information

Drug NameELB-011
Drug Alias NameELB-011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCD160 antigen inhibitors
TargetsCD160 antigen
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElsalys Biotech
China Registration ClassN/A

Develop Information

Active CompaniesElsalys Biotech
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A